SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Therapeutic Advances in Respiratory Disease
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Fernandes, L. B.
Right arrow Articles by Goldie, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernandes, L. B.
Right arrow Articles by Goldie, R. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Asthma
*COPD (Chronic Obstructive Pulmonary Disease)
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Review: Rho kinase as a therapeutic target in the treatment of asthma and chronic obstructive pulmonary disease

Lynette B. Fernandes

Pharmacology and Anaesthesiology Unit, School of Medicine & Pharmacology, and Western Australian Institute for Medical Research, The University of Western Australia, Perth, Australia

Peter J. Henry

Pharmacology and Anaesthesiology Unit, School of Medicine & Pharmacology, and Western Australian Institute for Medical Research, The University of Western Australia, Perth, Australia

Roy G. Goldie

Faculty of Health Sciences, Flinders University, Adelaide, Australia roy.goldie{at}flinders.edu.au

Asthma is a complex inflammatory disease of the airways involving reversible bronchoconstriction. Chronic obstructive pulmonary disease is typified by inflammation and airflow limitation that has an irreversible component. There is now substantial evidence that Rho kinase is involved in many of the pathways that contribute to the pathologies associated with these respiratory diseases including bronchoconstriction, airway inflammation, airway remodelling, neuromodulation and exacerbations due to respiratory tract viral infection. Indeed the Rho kinase inhibitor Y-27632 causes bronchodilatation and reduces pulmonary eosinophilia trafficking and airways hyperresponsiveness. Furthermore, accumulating evidence suggests that inhibition of Rho kinase could have a major beneficial impact on symptoms and disease progression in asthma and COPD by modulating several other systems and processes. Thus, the Rho kinase pathway may indeed be a worthwhile therapeutic target in the treatment of asthma and chronic obstructive pulmonary disease.

Key Words: Rho kinase • asthma • chronic obstructive pulmonary disease • bronchoconstriction • airway hyperresponsiveness • airway inflammation • neuromodulation • respiratory tract viral infection • Y-27632.

References

  • Adachi, T. et al. (2001) The functional role of Rho and Rho-associated coiled-coil forming protein kinase in eotaxin signaling of eosinophils. J Immunol 167: 4609—4615.[Abstract/Free Full Text]
  • Alblas, J. et al. (2001) Activation of RhoA and ROCK are essential for detachment of migrating leukocytes. Mol Biol Cell 12: 2137—2145.[Abstract/Free Full Text]
  • Bardi, G. et al. (2003) Rho kinase is required for CCR7-mediated polarization and chemotaxis of T lymphocytes. FEBS Lett 542: 79—83.[CrossRef][Medline] [Order article via Infotrieve]
  • Barnes, P.J. (2004) The role of anticholinergics in chronic obstructive pulmonary disease. Am J Med 117: 24S—32S.[Medline] [Order article via Infotrieve]
  • Barnes, P.J. (2006) Drugs for asthma. Br J Pharmacol 147: S297—S303.[CrossRef][Medline] [Order article via Infotrieve]
  • Belvisi, M.G. et al. (1996) Paradoxical facilitation of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by isoprenaline. Br J Pharmacol 117: 1413—1420.[Medline] [Order article via Infotrieve]
  • Blundell, R. et al. (2004) Emphysema: the challenge of the remodelled lung. J Pathol 202: 141—144.[CrossRef][Medline] [Order article via Infotrieve]
  • Burdyga, T. et al. (2003) Force and myosin light chain phosphorylation in dog airway smooth muscle activated in different ways. Respir Physiol Neurobiol 137: 141—149.[CrossRef][Medline] [Order article via Infotrieve]
  • Burke, E. et al. (2000) Profilin is required for optimal actin-dependent transcription of respiratory syncytial virus genome RNA. J Virol 74: 669—675.[Abstract/Free Full Text]
  • Buyukafsar, K. and Levent, A. (2003) Involvement of Rho/Rho-kinase signalling in the contractile activity and acetylcholine release in the mouse gastric fundus. Biochem Biophys Res Commun 303: 777—781.[CrossRef][Medline] [Order article via Infotrieve]
  • Carlin, S.M. et al. (2003) Urokinase poteniates PDGF-induced chemotaxis of human airway smooth muscle cells. Am J Physiol 284: L1020—L1026.
  • Cataldo, D.D. et al. (2003) Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors. Cell Mol Biol 49: 875—884.[Medline] [Order article via Infotrieve]
  • Celli, B.R. and MacNee, W. (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23: 932—946.[Free Full Text]
  • Chhabra, S.K. and Pandey, K.K. (2002) Comparison of acute bronchodilator effects of inhaled ipratropium bromide and salbutamol in bronchial asthma. J Asthma 39: 375—381.[CrossRef][Medline] [Order article via Infotrieve]
  • Costello, R.W. et al. (2000) Eosinophils and airway nerves in asthma. Histol Histopathol 15: 861—868.[Medline] [Order article via Infotrieve]
  • Davies, D.E. et al. (2003) Airway remodelling in asthma: new insights. J Allergy Clin Immunol 111: 215—225.[CrossRef][Medline] [Order article via Infotrieve]
  • De, B.P. and Banerjee, A.K. (1999) Involvement of actin microfilaments in the transcription/replication of human parainfluenza virus type 3: possible role of actin in other viruses. Microsc Res Techniq 47: 114—123.[CrossRef][Medline] [Order article via Infotrieve]
  • De Haas, J.R. et al. (1999) Facilitatory b2-adrenoceptors on cholinergic and adrenergic nerve endings of the guinea pig trachea. Am J Physiol 276: L420—L425.[Medline] [Order article via Infotrieve]
  • Doussau, F. et al. (2000) A Rho-related GTPase is involved in Ca(2+)-dependent neurotransmitter exocytosis. J Biol Chem 275: 7764—7770.[Abstract/Free Full Text]
  • Ediger, T.L. et al. (2003) Transcription factor activation and mitogenic synergism in airway smooth muscle cells. Eur Respir J 21: 759—769.[Abstract/Free Full Text]
  • Fernandes, L. et al. (2006) A Rho-kinase inhibitor, Y-27632, reduces cholinergic contraction but not neurotransmitter release. Eur J Pharmacol 550: 155—161.[CrossRef][Medline] [Order article via Infotrieve]
  • Fukata, Y. et al. (2001) Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganisation of non-muscle cells. Trends Pharmacol Sci 22: 32—39.[CrossRef][Medline] [Order article via Infotrieve]
  • Gleich, G.J. et al. (1988) The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J Allergy Clin Immunol 81: 776—781.[CrossRef][Medline] [Order article via Infotrieve]
  • Gosens, R. et al. (2004a) Growth factor-induced contraction of human bronchial smooth muscle is Rho-kinase-dependent. Eur J Pharmacol 494: 73—76.[CrossRef][Medline] [Order article via Infotrieve]
  • Gosens, R. et al. (2004b) Role of Rho-kinase in maintaining airway smooth muscle contractile phenotype. Eur J Pharmacol 483: 71—78.[CrossRef][Medline] [Order article via Infotrieve]
  • Gower, T.L. and Graham, B.S. (2001) Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro. Antimicrob Agents Chemother 45: 1231—1237.[Abstract/Free Full Text]
  • Gower, T.L. et al. (2001) RhoA is activated during respiratory syncytial virus infection. Virology 283: 188—196.[CrossRef][Medline] [Order article via Infotrieve]
  • Gupta, S. et al. (1998) Involvement of actin microfilaments in the replication of human parainfluenza virus type 3. J Virol 72: 2655—2662.[Abstract/Free Full Text]
  • Han, S. et al. (2005) Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase. Cancer Lett 219: 71—81.[CrossRef][Medline] [Order article via Infotrieve]
  • Hashimoto, K. et al. (2002) Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor. Thorax 57: 524—527.[Abstract/Free Full Text]
  • Henry, P.J. et al. (2005) A Rho kinase inhibitor, Y-27632 inhibits pulmonary eosinophilia, bronchoconstriction and airways hyperresponsiveness in allergic mice. Pulm Pharmacol Ther 18: 67—74.[CrossRef][Medline] [Order article via Infotrieve]
  • Hertz, M.I. et al. (1989) Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature. Medicine 68: 269—281.[Medline] [Order article via Infotrieve]
  • Hirano, K. et al. (2003) Protein kinase network in the regulation of phosphorylation and dephosphorylation of smooth muscle light chain. Mol Cell Biochem 248: 105—111.[CrossRef][Medline] [Order article via Infotrieve]
  • Hogg, J.C. et al. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. New Engl J Med 350: 2645—2653.[Abstract/Free Full Text]
  • Hocking, D.C. (2002) Fibronectin matrix deposition and cell contractility: implications for airway remodelling in asthma. Chest 122: 275S—278S.[CrossRef][Medline] [Order article via Infotrieve]
  • Honing, H. et al. (2004) RhoA activation promotes transendothelial migration of monocytes via ROCK. J Leukoc Biol 75: 523—528.[Abstract/Free Full Text]
  • Iizuka, K. et al. (2000) Evaluation of Y-27632, a rho-kinase inhibitor, as a bronchodilator in guinea pigs. Eur J Pharmacol 406: 273—279.[CrossRef][Medline] [Order article via Infotrieve]
  • Ito, K. et al. (2006) Update on glucocorticoid action and resistance. J Allergy Clin Immunol 117: 522—543.[CrossRef][Medline] [Order article via Infotrieve]
  • Jacoby, D.B. and Fryer, A.D. (2001) Anticholinergic therapy for airway diseases. Life Sci 68: 2565—2572.[CrossRef][Medline] [Order article via Infotrieve]
  • Jartti, T. (2001) Asthma, asthma medication and autonomic nervous system dysfunction. Clin Physiol 21: 260—269.[CrossRef][Medline] [Order article via Infotrieve]
  • Johnston, S.L. et al. (1995) Community study of role of viral infections in exacerbations of asthma in 9—11 year old children. Br Med J 310: 1225—1228.[Abstract/Free Full Text]
  • Kaibuchi, K. et al. (1999) Regulation of cadherin-mediated cell-cell adhesion by the Rho family GTPases. Curr Opin Cell Biol 11: 591—596.[CrossRef][Medline] [Order article via Infotrieve]
  • Katoh, K. et al. (2001a) Stress fiber organization regulated by MLCK and Rho-kinase in cultured human fibroblasts. Am J Physiol 280: C1669—C1679.
  • Katoh, K. et al. (2001b) Rho-kinase—mediated contraction of isolated stress fibers. J Cell Biol 153: 569—584.[Abstract/Free Full Text]
  • Kay, A.B. et al. (2005) The role of eosinophils in the pathogenesis of asthma. Trends Mol Med 11: 148—152.[CrossRef][Medline] [Order article via Infotrieve]
  • Kobayashi, M. et al. (2001) A pivotal role of Rho GTPase in the regulation of morphology and function of dendritic cells. J Immunol 167: 3583—3591.
  • Leigh, R. et al. (2002) Effects of montelukast and budesonide on airway responses and airway inflammation in asthma. Am J Respir Crit Care Med 166: 1212—1217.[Abstract/Free Full Text]
  • Levent, A. and Buyukafsar, K. (2004) Expression of Rho-kinase (ROCK-1 and ROCK-2) and its substantial role in the contractile activity of the sheep ureter. Br J Pharmacol 143: 431—437.[CrossRef][Medline] [Order article via Infotrieve]
  • Matsumura, F. et al. (1998) Specific localization of serine 19 phosphorylated myosin II during cell locomotion and mitosis of cultured cells. J Cell Biol 140: 119—129.[Abstract/Free Full Text]
  • Nicholson, K.G. et al. (1993) Respiratory viruses and exacerbations of asthma in adults. Br Med J 307: 982—986.[Abstract/Free Full Text]
  • Nishiguchi, F. et al. (2003) Different migratory and proliferative properties of smooth muscle cells of coronary and femoral artery. Atherosclerosis 171: 39—47.[CrossRef][Medline] [Order article via Infotrieve]
  • Ohashi, Y. et al. (1992) Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am Review Respir Dis 145: 1469—1476.
  • Pfitzer, G. (2001) Invited review: regulation of myosin phosphorylation in smooth muscle. J Appl Physiol 91: 497—503.[Abstract/Free Full Text]
  • Parameswaran, K. et al. (2002) Cysteinyl leukotrienes promote human airway smooth muscle migration. Am J Respir Crit Care Med 166: 738—742.[Abstract/Free Full Text]
  • Pastey, M.J. et al. (1999) RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation. J Virol 73: 7262—7270.[Abstract/Free Full Text]
  • Pastey, M.J. et al. (2000) A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3. Nature Med 6: 35—40.[CrossRef][Medline] [Order article via Infotrieve]
  • Perry, T.T. et al. (2004) Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposure. Annals Allergy Asthma Immunol 93: 431—438.
  • Redington, A.E. and Howarth, P.H. (1997) Airway wall remodelling in asthma. Thorax 52: 310—312.[Medline] [Order article via Infotrieve]
  • Rodrigo, G.J. and Rodrigo, C. (2002) The role of anticholinergics in acute asthma treatment, an evidence-based evaluation. Chest 121: 1977—1987.[CrossRef][Medline] [Order article via Infotrieve]
  • Rohde, G. et al. (2003) Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 58: 37—42.[Abstract/Free Full Text]
  • Saito, H. et al. (2002) Endothelial Rho and Rho kinase regulate neutrophil migration via endothelial myosin light chain phosphorylation. J Leukoc Biol 72: 829—836.[Abstract/Free Full Text]
  • Seemungal, T. et al. (2001) Respiratory viruses, symptoms and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164: 1618—1623.[Abstract/Free Full Text]
  • Symons, M. and Rusk, N. (2003) Control of vesicular trafficking by Rho GTPases. Current Biol 13: R409—R418.[CrossRef][Medline] [Order article via Infotrieve]
  • Takeda, N. et al. (2006) Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin. Am J Respir Cell Mol Biol 35: 722—729.[Abstract/Free Full Text]
  • Tanaka, K. and Takai, Y. (1998) Control of reorganization of the actin cytoskeleton by Rho family small GTP-binding proteins in yeast. Curr Opin Cell Biol 10: 112—116.[CrossRef][Medline] [Order article via Infotrieve]
  • Tkach, V. et al. (2005) The role of RhoA in the regulation of cell morphology and motility. Cell Motil Cytoskeleton 61: 21—33.[CrossRef][Medline] [Order article via Infotrieve]
  • Treanor, J. and Falsey, A. (1999) Respiratory viral infections in the elderly. Antivir Res 44: 79—102.[CrossRef][Medline] [Order article via Infotrieve]
  • Ulloa, L. et al. (1998) Interactions between cellular actin and human respiratory syncytial virus (HRSV). Virus Res 53: 13—25.[CrossRef][Medline] [Order article via Infotrieve]
  • Upham, J.W. and Stick, S.M. (2006) Interactions between airway epithelial cells and dendritic cells: implications for the regulation of airway inflammation. Current Drug Targets 7: 541—545.
  • Volovitz, B. et al. (1999) Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma. J Allergy Clin Immunol 104: 1162—1167.[CrossRef][Medline] [Order article via Infotrieve]
  • Walsh, E.E. and Graham, B.S. (1999) Respiratory syncytial viruses. In Dolin R and Wright P F (ed), Lung biology in health and disease, vol 127, Viral infections of the respiratory tract, Marcel Dekker Inc.: New York.
  • Watt, A.P. et al. (2005) Neutrophils and eosinophils: clinical implications of their appearance, presence and disappearance in asthma and COPD. Current Drug Targets — Inflammation Allergy 4: 415—423.
  • Wendt, C.H. et al. (1995) Paramyxovirus infection in lung transplant recipients. J Heart Lung Transplant 14: 479—485.[Medline] [Order article via Infotrieve]
  • Westby, M. et al. (2004) Anticholinergic agents for chronic asthma in adults. Cochrane Database System Rev 3: CD003269.
  • Wibberley, A. et al. (2003) Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle. Br J Pharmacol 138: 757—766.[CrossRef][Medline] [Order article via Infotrieve]
  • Wraight, J.M. et al. (2003) Bronchodilator tolerance: the impact of increasing bronchoconstriction. Eur Respir J 21: 810—815.[Abstract/Free Full Text]
  • Yamagata, S. et al. (2000) Effect of calcium sensitisation modulator, Y-27632, on isolated human bronchus and pulmonary artery. Pulm Pharmacol Ther 13: 25—29.[CrossRef][Medline] [Order article via Infotrieve]
  • Yoshii, A. et al. (1999) Relaxation of contracted rabbit tracheal and human bronchial smooth muscle by Y-27632 through inhibition of Ca2+ sensitization. Am J Respir Cell Mol Biol 20: 1190—1200.[Abstract/Free Full Text]
  • Zhang, X.Y. et al. (1995) ß2-Adrenoceptor activation augments acetylcholine release from tracheal parasympathetic nerves. Am J Physiol 12: L950—L956.

Therapeutic Advances in Respiratory Disease, Vol. 1, No. 1, 25-33 (2007)
DOI: 10.1177/1753465807080740


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Fernandes, L. B.
Right arrow Articles by Goldie, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernandes, L. B.
Right arrow Articles by Goldie, R. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Asthma
*COPD (Chronic Obstructive Pulmonary Disease)
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement